Inhibition of Cryoglobulin/RF-Mediated Skin Vasculitis in FcRγ −/− Mice
FcRγ . | 6-19 . | No. . | Serum IgG3 (mg/mL) . | Ear Lesions . | Kidney Lesions . | Serum BUN (mg/dL) . |
---|---|---|---|---|---|---|
+/− | + | 11 | 8.42 ± 4.17* | 11/11† | 11/11 | 150.0 ± 69.0* |
− | 3 | <0.01 | 0/3 | 0/3 | 20.0 ± 2.2 | |
−/− | + | 12 | 8.28 ± 2.92 | 0/12 | 12/12 | 153.1 ± 99.9 |
− | 3 | <0.01 | 0/3 | 0/3 | 19.9 ± 7.7 |
FcRγ . | 6-19 . | No. . | Serum IgG3 (mg/mL) . | Ear Lesions . | Kidney Lesions . | Serum BUN (mg/dL) . |
---|---|---|---|---|---|---|
+/− | + | 11 | 8.42 ± 4.17* | 11/11† | 11/11 | 150.0 ± 69.0* |
− | 3 | <0.01 | 0/3 | 0/3 | 20.0 ± 2.2 | |
−/− | + | 12 | 8.28 ± 2.92 | 0/12 | 12/12 | 153.1 ± 99.9 |
− | 3 | <0.01 | 0/3 | 0/3 | 19.9 ± 7.7 |
FcRγ +/− or FcRγ −/− mice were inoculated with 6-19 hybridoma cells as described in Materials and Methods. Blocks of the ear and kidney as well as blood samples were collected when the FcRγ +/− mice exhibited skin purpura (7 to 12 days after 6-19 administration).
Values for serum IgG3 and BUN represent the mean ± SD and were determined at time of death.
Criteria for positive lesions are described in Materials and Methods.